InvestorsObserver
×
News Home

Is Meridian Bioscience Inc (VIVO) a Leader in the Healthcare Sector?

Thursday, January 12, 2023 03:31 PM | InvestorsObserver Analysts

Mentioned in this article

Is Meridian Bioscience Inc (VIVO) a Leader in the Healthcare Sector?

Meridian Bioscience Inc (VIVO) is near the top in its sector according to InvestorsObserver. VIVO gets an overall rating of 95. That means it scores higher than 95% of stocks. Meridian Bioscience Inc gets a 86 rank in the Healthcare sector. Healthcare is number 3 out of 11 sectors.

Overall Score - 95
VIVO has an Overall Score of 95. Find out what this means to you and get the rest of the rankings on VIVO!

What do These Ratings Mean?

Analyzing stocks can be hard. There are tons of numbers and ratios, and it can be hard to remember what they all mean and what counts as “good” for a given value. InvestorsObserver ranks stocks on eight different metrics. We percentile rank most of our scores to make it easy for investors to understand. A score of 95 means the stock is more attractive than 95 percent of stocks. These rankings allows you to easily compare stocks and view what the strengths and weaknesses are of a given company. This lets you find the stocks with the best short and long term growth prospects in a matter of seconds. The combined score incorporates technical and fundamental analysis in order to give a comprehensive overview of a stocks performance. Investors who then want to focus on analysts rankings or valuations are able to see the separate scores for each section.

What's Happening With Meridian Bioscience Inc Stock Today?

Meridian Bioscience Inc (VIVO) stock is trading at $33.60 as of 3:30 PM on Thursday, Jan 12, an increase of $0.02, or 0.07% from the previous closing price of $33.58. Volume today is light. So far 255,037 shares have traded compared to average volume of 612,267 shares. The stock has traded between $33.53 and $33.63 so far today. Click Here to get the full Stock Report for Meridian Bioscience Inc stock.

You May Also Like

Get the InvestorsObserver App

InvestorsObserver App
iOS App Android App